News
Risk of Uterine Diseases, Cancers Up With Tamoxifen Treatment
After adjustment for confounding variables, risk of endometrial cancer was increased almost fourfold with tamoxifen treatment
Your search for hypertension returned 1945 results
News
Continuing ACE Inhibitors Despite Potassium Change Can Have Benefits
Stopping renin-angiotensin-aldosterone inhibitors after hyperkalemia may offset their potential clinical benefits, according to investigators.
ACR 2022
Weak Association Observed Between Systemic Vasculitis and Myocardial Infarction
Patients with vasculitis aged older than 40 years who had been admitted to teaching hospitals were included in the study.
News
Baxdrostat Studied in Treatment-Resistant Hypertension
Dose-dependent reductions in systolic blood pressure seen in phase 2 dose-ranging study
News
Telmisartan Linked to Reduced Risk for Alzheimer Disease in Black Patients
African American-specific beneficial effects of telmisartan identified in Mendelian randomization analysis
Drugs in the Pipeline
Semaglutide Reduces BMI More Than Lifestyle Changes in Teens With Obesity
Semaglutide is a glucagon-like peptide-1 receptor agonist.
News
Meta-Analysis Shows Decrease in Dementia Risk With HTN Treatment
Lowering blood pressure with antihypertensive treatment may reduce risk for incident dementia in older adults with a history of hypertension
News
Budesonide Improves Kidney Parameters in IgA Nephropathy
The budesonide formulation was Nefecon, a corticosteroid that is believed to target mucosal B-cells in the ileum producing galactose-deficient IgA1 antibodies
MPR Weekly Dose Podcast
MPR Weekly Dose Podcast #136
Approvals for relapsed or refractory multiple myeloma, non-radiographic axial spondyloarthritis, and unresectable hepatocellular carcinoma; advisory committee takes vote on potential treatment for anemia of chronic kidney disease; and an oral formulation of pulmonary arterial hypertension treatment.
Safety Alerts and Recalls
Quinapril-Hydrochlorothiazide Tablets Recalled Due to Nitrosamine Impurity
Long-term use of a product containing N-nitroso-quinapril may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.
